VV Manager
Latest statistics and disclosures from VV Manager's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALLO, Oyster Point Pharma, Homology Medicines, Sutro Biopharma, and represent 100.00% of VV Manager's stock portfolio.
- Reduced shares in these 2 stocks: ALLO (-$21M), Sutro Biopharma.
- VV Manager was a net seller of stock by $-22M.
- VV Manager has $114M in assets under management (AUM), dropping by 28.84%.
- Central Index Key (CIK): 0001735804
Tip: Access up to 7 years of quarterly data
Positions held by VV Manager consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for VV Manager
VV Manager holds 4 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Allogene Therapeutics (ALLO) | 67.5 | $77M | -21% | 1.8M | 42.82 |
|
| Oyster Point Pharma | 19.7 | $23M | 779k | 28.88 |
|
|
| Homology Medicines | 10.3 | $12M | 771k | 15.19 |
|
|
| Sutro Biopharma | 2.5 | $2.8M | -21% | 366k | 7.76 |
|
Past Filings by VV Manager
SEC 13F filings are viewable for VV Manager going back to 2018
- VV Manager 2020 Q2 filed Aug. 4, 2020
- VV Manager 2020 Q1 filed April 10, 2020
- VV Manager 2019 Q4 filed Jan. 8, 2020
- VV Manager 2019 Q3 filed Oct. 15, 2019
- VV Manager 2019 Q2 filed July 10, 2019
- VV Manager 2018 Q4 restated filed April 11, 2019
- VV Manager 2019 Q1 filed April 11, 2019
- VV Manager 2018 Q4 filed Feb. 27, 2019